Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?
Primary Purpose
Nasal Obstruction
Status
Withdrawn
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Ketamine i.v
Sponsored by
About this trial
This is an interventional supportive care trial for Nasal Obstruction
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing submucosal resection of nasal septum with or without turbinectomy.
- Over 18 years of age.
- ASA (anesthsiology Severity Score) score of 1-2.
- Signed informed consent by patient or caregiver.
Exclusion Criteria:
- Allergy to Ketamine
- Unable/ unwilling to comply with the protocol requirements
- Pregnancy or breast feeding
- Chronic use of analgetics
- History of alcohol and/or drug abuse
- Previous nasal surgry
Sites / Locations
- Galillee medical center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
0.5 mg/kg body weight Ketamin
5 ml normal saline as placebo
Arm Description
Patients allocated to this arm will receive an iv dose of 0.5 mg/kg body weight ketamine.
Patients allocated to this arm will receive an iv dose of 5ml saline as placebo.
Outcomes
Primary Outcome Measures
Pain: reduction in severity based on VAS score.
The post operative analgetic effect will be assessed by the amount of analgesia required in the post-operative period and by regular pain measurements using VAS (Visual Analogue Scale) - at 0.5 hours post operation in the recovery room, 8 hours post operation and the morning of first post operative day
consumption of postoperative pain medication type, dosage and reduction in the demand postoperatively.
The data will be collected from the medical file
Secondary Outcome Measures
Readmission for any reason.
Duration of hospital stay.
Full Information
NCT ID
NCT02294162
First Posted
November 14, 2014
Last Updated
October 1, 2018
Sponsor
Western Galilee Hospital-Nahariya
1. Study Identification
Unique Protocol Identification Number
NCT02294162
Brief Title
Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?
Official Title
Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Terminated by IRB
Study Start Date
April 1, 2015 (Actual)
Primary Completion Date
October 1, 2017 (Actual)
Study Completion Date
October 1, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Western Galilee Hospital-Nahariya
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pain is an unpleasant sensory experience associated with actual or potential tissue damage. Acute pain management is an important aspect of perioperative anesthetic care. Moreover, it is the most important factor related to patient discomfort after surgery. Adequate pain management, ideally resulting in the complete absence of postoperative pain, not only provides comfort to patients, but may also contribute to improved healing and a reduction in the incidence of postoperative complications. Inadequate postoperative analgesia has been shown to contribute to adverse outcomes, including, but not limited to, immunosuppression, hyperglycemia, poor rehabilitation, and progression to chronic pain.
Detailed Description
Patients who are scheduled for submucosal resection of nasal septum with or without turbinectomy will be recruited for the study The patients will be will be assigned to either the treatment group who will be administered ketamine prior to the operation or the control group who will receive a normal saline injection, both in identicle syringes.
All patients will be operated on by the same surgoens and by the same method of dissection and hemostasis (2-5 2 ml lidocadrain carpules, monopolar suction-cautery set on 25).
Patients folow-up will be reported in their medical charts. The post operative analgetic effect will be assessed by the amount of analgesia required in the post-operative period and by regular pain measurements using VAS (Visual Analogue Scale) - at 0.5 hours post operation in the recovery room, 8 hours post operation and the morning of first post operative day in the otolaryngology - head and neck department
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nasal Obstruction
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
0.5 mg/kg body weight Ketamin
Arm Type
Experimental
Arm Description
Patients allocated to this arm will receive an iv dose of 0.5 mg/kg body weight ketamine.
Arm Title
5 ml normal saline as placebo
Arm Type
Placebo Comparator
Arm Description
Patients allocated to this arm will receive an iv dose of 5ml saline as placebo.
Intervention Type
Drug
Intervention Name(s)
Ketamine i.v
Primary Outcome Measure Information:
Title
Pain: reduction in severity based on VAS score.
Description
The post operative analgetic effect will be assessed by the amount of analgesia required in the post-operative period and by regular pain measurements using VAS (Visual Analogue Scale) - at 0.5 hours post operation in the recovery room, 8 hours post operation and the morning of first post operative day
Time Frame
the morning of first post operative day
Title
consumption of postoperative pain medication type, dosage and reduction in the demand postoperatively.
Description
The data will be collected from the medical file
Time Frame
the morning of first post operative day
Secondary Outcome Measure Information:
Title
Readmission for any reason.
Time Frame
one week
Title
Duration of hospital stay.
Time Frame
one week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing submucosal resection of nasal septum with or without turbinectomy.
Over 18 years of age.
ASA (anesthsiology Severity Score) score of 1-2.
Signed informed consent by patient or caregiver.
Exclusion Criteria:
Allergy to Ketamine
Unable/ unwilling to comply with the protocol requirements
Pregnancy or breast feeding
Chronic use of analgetics
History of alcohol and/or drug abuse
Previous nasal surgry
Facility Information:
Facility Name
Galillee medical center
City
Naharia
ZIP/Postal Code
2210001
Country
Israel
12. IPD Sharing Statement
Learn more about this trial
Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?
We'll reach out to this number within 24 hrs